Covariate | Comparison group (n = 100) | Transitions (n = 38) | p-value1 | |
---|---|---|---|---|
Demographics | ||||
Age: Mean (S.D.) | 49 (9) | 49 (9) | 0.98 | |
Male gender | 90 (90%) | 35 (92%) | 0.71 | |
Race | Black/African-American | 52 (52%) | 17 (45%) | 0.09 |
Hispanic/Latino | 46 (46%) | 17 (45%) | ||
Other2 | 2 (2%) | 4 (11%) | ||
HIV variables | ||||
VL suppressed at care initiation | 29 (29%) | 22 (58%) | < 0.01 | |
Recent HIV diagnosis3 | 19 (18%) | 2 (5%) | 0.04 | |
Reported years diagnosed with HIV4 (S.D.) | 11.0 (9.5) | 14.8 (8.7) | 0.03 | |
On ART during follow-up | 90 (90%) | 37 (97%) | 0.18 | |
HIV risk factor | Heterosexual | 58 (58%) | 20 (53%) | 0.57 |
MSM5 | 33 (32%) | 2 (5%) | < 0.01 | |
Injection drug use | 12 (12%) | 20 (53%) | < 0.01 | |
Transfusion | 1 (1%) | 0 (0%) | N/A | |
Unknown | 1 (1%) | 4 (11%) | < 0.01 | |
Comorbidities | ||||
Chronic illness6 | 67 (67%) | 24 (63%) | 0.67 | |
Hepatitis C infection | 19 (19%) | 25 (66%) | < 0.01 | |
Current substance use disorder | 24 (24%) | 22 (58%) | < 0.01 | |
Current opioid use disorder7 | 12 (12%) | 21 (55%) | < 0.01 | |
Current cocaine use disorder | 5 (5%) | 8 (21%) | < 0.01 | |
Current alcohol use disorder | 9 (9%) | 5 (13%) | 0.47 | |
Psychiatric illness8 | 39 (39%) | 20 (53%) | 0.15 | |
Chronic non-malignant pain9 | 39 (39%) | 21 (55%) | 0.09 | |
Current smoking | 41 (41%) | 30 (79%) | < 0.01 | |
Receiving buprenorphine maintenance treatment | 2 (2%) | 11 (29%) | < 0.01 | |
Receiving prescription opioid analgesics10 | 21 (21%) | 3 (8%) | 0.08 |